Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,435.00
Bid: 1,432.00
Ask: 1,435.00
Change: 13.00 (0.91%)
Spread: 3.00 (0.209%)
Open: 1,427.00
High: 1,435.00
Low: 1,395.00
Prev. Close: 1,422.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

3 Aug 2016 10:05

RNS Number : 1169G
Indivior PLC
03 August 2016
 

INDIVIOR PLC (the 'Company')

NOTIFICATION OF TRANSACTIONS BY DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY

The Company announces that on August 2, 2016 it made a conditional award ('Award') over ordinary shares of US$0.10 in the Company ('Shares') under the terms of the Indivior Long-Term Incentive Plan (the 'LTIP') to a person discharging managerial responsibilities ('PDMR'), as set out below:

Name

Maximum number of Shares under Award

Ingo Elfering

99,733

 

The vesting of the Award is subject to the rules of the LTIP and is conditional upon continued employment and the achievement of performance conditions. The performance conditions applicable to the Award are based on (1) key pipeline milestones; (2) Relative Total Shareholder Return ("TSR") to the TSR of the constituents of the FTSE250 (excluding investment trusts); and (3) Relative TSR to the TSR constituents of the S&P1500 Pharmaceutical and Biotech Index (one-third weighting for each measure).

The number of Shares under the Award that will vest will depend upon the extent to which the performance conditions have been achieved.

No consideration was payable on the grant of the Award. The Award will normally vest on the third anniversary of the Award date.

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

1.

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Ingo Elfering

b)

Position / status

Chief Information Officer

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

 

Name

Indivior PLC

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of US$0.10

ISIN: GB00BRS65X63

b)

Nature of the transaction

Award over Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£2.8162

99,733

d)

Aggregated information

Aggregated volume Price

99,733 Ordinary Shares

£2.8162

e)

Date of the transaction

02/08/2016

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Kathryn Hudson

Company Secretary

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUGUWURUPQUBW
Date   Source Headline
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
23rd Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 202311:51 amRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSTransaction in Own Shares
20th Nov 20233:33 pmRNSDirector/PDMR Shareholding
20th Nov 20232:55 pmRNSIndivior to Participate in Upcoming Investor Event
20th Nov 202312:56 pmRNSDirector/PDMR Shareholding
20th Nov 20239:37 amRNSHolding(s) in Company
17th Nov 202311:37 amRNSShare Repurchase Program
17th Nov 202310:00 amRNSHolding(s) in Company
17th Nov 20239:59 amRNSHolding(s) in Company
17th Nov 20237:00 amRNSAmendment to Relationship Agreement with Scopia
16th Nov 20232:00 pmRNSIndivior to Participate in Upcoming Conference
15th Nov 20232:54 pmRNSHolding(s) in Company
15th Nov 202310:23 amRNSHolding(s) in Company
10th Nov 202310:17 amRNSBlock listing Interim Review
9th Nov 20237:01 amRNSAppointment of Independent Non-Executive Director
9th Nov 20237:00 amRNS3rd Quarter Results
1st Nov 20234:00 pmRNSIndivior to Participate in Upcoming Conference
26th Oct 202311:51 amRNSHolding(s) in Company
23rd Oct 20237:00 amRNSIndivior settles Antitrust MDL with DPs
13th Oct 202312:14 pmRNSHolding(s) in Company
5th Oct 20233:30 pmRNSNotice of Results
21st Aug 20237:00 amRNSIndivior settles Antitrust MDL with End Payors
1st Aug 20234:00 pmRNSTotal Voting Rights
27th Jul 20237:00 amRNSHalf-year Report
26th Jul 20234:00 pmRNSHolding(s) in Company
24th Jul 20234:00 pmRNSHolding(s) in Company
10th Jul 20234:00 pmRNSHolding(s) in Company
5th Jul 20234:00 pmRNSHolding(s) in Company
30th Jun 20234:00 pmRNSDirector Declaration
29th Jun 20234:00 pmRNSHolding(s) in Company
27th Jun 202311:00 amRNSNotice of Results
21st Jun 20234:00 pmRNSHolding(s) in Company
16th Jun 20234:00 pmRNSHolding(s) in Company
15th Jun 20234:00 pmRNSHolding(s) in Company
14th Jun 20234:00 pmRNSHolding(s) in Company
14th Jun 20234:00 pmRNSHolding(s) in Company
13th Jun 20234:00 pmRNSHolding(s) in Company
12th Jun 20237:00 amRNSIndivior to Commence Trading on Nasdaq
7th Jun 20233:45 pmRNSHolding(s) in Company
2nd Jun 20235:17 pmRNSIndivior settles antitrust MDL with states and DC
1st Jun 20239:11 amRNSTotal Voting Rights
26th May 20234:20 pmRNSHolding(s) in Company
25th May 20232:30 pmRNSIndivior to Participate in Upcoming Conferences
24th May 20233:05 pmRNSHolding(s) in Company
23rd May 20236:05 pmRNSIndivior Files Form 20-F for US Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.